{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T07:48:42Z","timestamp":1743752922011},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Wu lien-the Youth Science Foundation of Harbin Medical University","award":["WLD-QN1405"],"award-info":[{"award-number":["WLD-QN1405"]}]},{"name":"The HMU Marshal Initiative Funding","award":["HMUMIF-21007"],"award-info":[{"award-number":["HMUMIF-21007"]}]},{"name":"The Postdoctoral Foundation of Heilongjiang Province","award":["LRB08-340"],"award-info":[{"award-number":["LRB08-340"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81373220"],"award-info":[{"award-number":["81373220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>MSM are at high risk of HIV infection. Previous studies have shown that the cell cycle regulation plays an important role in HIV-1 infection, especially at the G2\/M checkpoint. <jats:italic>ATR<\/jats:italic>, <jats:italic>Chk1<\/jats:italic>, <jats:italic>Cdc25C<\/jats:italic> and <jats:italic>CDK1<\/jats:italic> are key genes of G2\/M checkpoint. However, the association between SNPs of these genes and susceptibility to HIV-1 infection and AIDS progression remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, 42 tSNPs from the above four G2\/M checkpoint genes were genotyped in 529 MSM and 529 control subjects from northern China to analyze this association.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results showed that rs34660854 A and rs75368165 A in <jats:italic>ATR<\/jats:italic> gene and rs3756766 A in <jats:italic>Cdc25C<\/jats:italic> gene could increase the risk of HIV-1 infection (<jats:italic>P<\/jats:italic>\u2009=\u20090.049, OR\u2009=\u20091.234, 95% CI 1.001\u20131.521; <jats:italic>P<\/jats:italic>\u2009=\u20090.020, OR\u2009=\u20091.296, 95% CI 1.042\u20131.611; <jats:italic>P<\/jats:italic>\u2009=\u20090.011, OR\u2009=\u20091.392, 95% CI 1.080\u20131.794, respectively), while <jats:italic>Chk1<\/jats:italic> rs10893405 (<jats:italic>P<\/jats:italic>\u2009=\u20090.029, OR\u2009=\u20091.629, 95% CI 1.051\u20132.523) were significantly associated with AIDS progression. Besides, rs34660854 (<jats:italic>P<\/jats:italic>\u2009=\u20090.019, OR\u2009=\u20091.364, 95% CI 1.052\u20131.769; <jats:italic>P<\/jats:italic>\u2009=\u20090.022, OR\u2009=\u20091.337, 95% CI 1.042\u20131.716, under Codominant model and Dominant model, respectively) and rs75368165 (<jats:italic>P<\/jats:italic>\u2009=\u20090.006, OR\u2009=\u20091.445, 95% CI\u2009=\u20091.114\u20131.899; <jats:italic>P<\/jats:italic>\u2009=\u20090.007, OR\u2009=\u20091.418, 95% CI 1.099\u20131.831, under Codominant model and Dominant model, respectively) in <jats:italic>ATR<\/jats:italic> gene, rs12576279 (<jats:italic>P<\/jats:italic>\u2009=\u20090.013, OR\u2009=\u20090.343, 95% CI 0.147-0.800; <jats:italic>P<\/jats:italic>\u2009=\u20090.048, OR\u2009=\u20090.437, 95% CI 0.192\u20130.991, under Codominant model and Dominant model, respectively) and rs540436 (<jats:italic>P<\/jats:italic>\u2009=\u20090.012, OR\u2009=\u20091.407, 95% CI 1.077\u20131.836; <jats:italic>P<\/jats:italic>\u2009=\u20090.021, OR\u2009=\u20091.359, 95% CI 1.048\u20131.762, under Codominant model and Dominant model, respectively) in <jats:italic>Chk1<\/jats:italic> gene, rs3756766 (<jats:italic>P<\/jats:italic>\u2009=\u20090.013, OR\u2009=\u20091.455, 95% CI 1.083\u20131.954; <jats:italic>P<\/jats:italic>\u2009=\u20090.009, OR\u2009=\u20091.460, 95% CI 1.098\u20131.940, under Codominant model and Dominant model, respectively) in <jats:italic>Cdc25C<\/jats:italic> gene and rs139245206 (<jats:italic>P<\/jats:italic>\u2009=\u20090.022, OR\u2009=\u20095.011, 95% CI 1.267\u201319.816; <jats:italic>P<\/jats:italic>\u2009=\u20090.020, OR\u2009=\u20095.067, 95% CI 1.286\u201319.970, under Codominant model and Recessive model, respectively) in <jats:italic>CDK1<\/jats:italic> gene were significantly associated with HIV-1 infection under different models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found that genetic variants of G2\/M checkpoint genes had a molecular influence on the occurrence of HIV-1 infection and AIDS progression in a northern Chinese MSM population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-023-00536-w","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T15:03:13Z","timestamp":1689778993000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomedical association analysis between G2\/M checkpoint genes and susceptibility to HIV-1 infection and AIDS progression from a northern chinese MSM population"],"prefix":"10.1186","volume":"20","author":[{"given":"Jiawei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keer","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songbin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuandong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"536_CR1","doi-asserted-by":"crossref","unstructured":"Hussein M, Molina MA, Berkhout B, Herrera-Carrillo E. A CRISPR-Cas cure for HIV\/AIDS. Int J Mol Sci Jan 13 2023;24(2).","DOI":"10.3390\/ijms24021563"},{"issue":"10","key":"536_CR2","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1016\/S1473-3099(20)30983-X","volume":"21","author":"V Guilamo-Ramos","year":"2021","unstructured":"Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, et al. Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV\/AIDS pandemic and emerging infectious disease outbreaks. Lancet Infect Dis Oct. 2021;21(10):e326\u201333.","journal-title":"Lancet Infect Dis Oct"},{"issue":"38","key":"536_CR3","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"28","author":"C Giacinti","year":"2006","unstructured":"Giacinti C, Giordano A. RB and cell cycle progression. Oncogene Aug. 2006;28(38):5220\u20137.","journal-title":"Oncogene Aug"},{"issue":"5","key":"536_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/joim.12609","volume":"281","author":"KG Wiman","year":"2017","unstructured":"Wiman KG, Zhivotovsky B. Understanding cell cycle and cell death regulation provides novel weapons against human diseases. J Intern Med May. 2017;281(5):483\u201395.","journal-title":"J Intern Med May"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-0888-2_2","volume":"1170","author":"KJ Barnum","year":"2014","unstructured":"Barnum KJ, O\u2019Connell MJ. Cell cycle regulation by checkpoints. Methods in molecular biology (Clifton N J). 2014;1170:29\u201340.","journal-title":"Methods in molecular biology (Clifton N J)"},{"issue":"5","key":"536_CR6","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1159\/000495899","volume":"51","author":"Q Luo","year":"2018","unstructured":"Luo Q, Guo H, Kuang P, et al. Sodium Fluoride Arrests Renal G2\/M phase cell-cycle progression by activating ATM-Chk2-P53\/Cdc25C signaling pathway in mice. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2018;51(5):2421\u201333.","journal-title":"Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol"},{"issue":"5","key":"536_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1101\/gad.1067403","volume":"1","author":"EJ Brown","year":"2003","unstructured":"Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes & development Mar. 2003;1(5):615\u201328.","journal-title":"Genes & development Mar"},{"issue":"51","key":"536_CR8","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1038\/sj.onc.1204942","volume":"8","author":"K Koniaras","year":"2001","unstructured":"Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O\u2019Connell MJ. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene Nov. 2001;8(51):7453\u201363.","journal-title":"Oncogene Nov"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-4615-4253-7_10","volume":"4","author":"I Nilsson","year":"2000","unstructured":"Nilsson I, Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000;4:107\u201314.","journal-title":"Prog Cell Cycle Res"},{"issue":"3","key":"536_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.cr.7290279","volume":"15","author":"RY Zhao","year":"2005","unstructured":"Zhao RY, Elder RT. Viral infections and cell cycle G2\/M regulation. Cell Res Mar. 2005;15(3):143\u20139.","journal-title":"Cell Res Mar"},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1743-422X-8-219","volume":"11","author":"K Sakai","year":"2011","unstructured":"Sakai K, Barnitz RA, Chaigne-Delalande B, Bidere N, Lenardo MJ. Human immunodeficiency virus type 1 vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest. Virol J May. 2011;11:8:219.","journal-title":"Virol J May"},{"issue":"11","key":"536_CR12","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1128\/jvi.69.11.6705-6711.1995","volume":"69","author":"J He","year":"1995","unstructured":"He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol Nov. 1995;69(11):6705\u201311.","journal-title":"J Virol Nov"},{"issue":"1","key":"536_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.virol.2003.10.007","volume":"5","author":"WC Goh","year":"2004","unstructured":"Goh WC, Manel N, Emerman M. The human immunodeficiency virus vpr protein binds Cdc25C: implications for G2 arrest. Virol Jan. 2004;5(1):337\u201349.","journal-title":"Virol Jan"},{"issue":"1","key":"536_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12977-018-0391-8","volume":"16","author":"K Iijima","year":"2018","unstructured":"Iijima K, Kobayashi J, Ishizaka Y. Structural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response. Retrovirology Jan. 2018;16(1):8.","journal-title":"Retrovirology Jan"},{"issue":"48","key":"536_CR15","doi-asserted-by":"publisher","first-page":"20798","DOI":"10.1073\/pnas.1008076107","volume":"30","author":"T Izumi","year":"2010","unstructured":"Izumi T, Io K, Matsui M, et al. HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc Natl Acad Sci United States Am Nov. 2010;30(48):20798\u2013803.","journal-title":"Proc Natl Acad Sci United States Am Nov"},{"issue":"12","key":"536_CR16","doi-asserted-by":"publisher","first-page":"e84489","DOI":"10.1371\/journal.pone.0084489","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Chen YL, Xie YT, et al. Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among chinese Han women. PLoS ONE. 2013;8(12):e84489.","journal-title":"PLoS ONE"},{"issue":"7","key":"536_CR17","doi-asserted-by":"publisher","first-page":"e68578","DOI":"10.1371\/journal.pone.0068578","volume":"8","author":"WY Lin","year":"2013","unstructured":"Lin WY, Brock IW, Connley D, et al. Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PLoS ONE. 2013;8(7):e68578.","journal-title":"PLoS ONE"},{"issue":"24","key":"536_CR18","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.3748\/wjg.v22.i24.5558","volume":"28","author":"YL Nan","year":"2016","unstructured":"Nan YL, Hu YL, Liu ZK, et al. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma. World J Gastroenterol Jun. 2016;28(24):5558\u201367.","journal-title":"World J Gastroenterol Jun"},{"issue":"2","key":"536_CR19","first-page":"263","volume":"15","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinf Jan. 2005;15(2):263\u20135.","journal-title":"Bioinf Jan"},{"key":"536_CR20","unstructured":"World Health Organization. WHO Case definitions of definitions of HIV for surveillance and revised clinical staging and inmunological classification of HIV-related disease in adults and children. ISBN 9789241595629. HIV\/AIDS Programme; 2007."},{"issue":"5","key":"536_CR21","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1128\/JVI.79.5.2973-2978.2005","volume":"79","author":"Y Ariumi","year":"2005","unstructured":"Ariumi Y, Turelli P, Masutani M, Trono D. DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration. J Virol Mar. 2005;79(5):2973\u20138.","journal-title":"J Virol Mar"},{"issue":"3","key":"536_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","volume":"18","author":"J Hemelaar","year":"2012","unstructured":"Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends in molecular medicine Mar. 2012;18(3):182\u201392.","journal-title":"Trends in molecular medicine Mar"},{"issue":"2","key":"536_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/viro.2001.1007","volume":"1","author":"RT Elder","year":"2001","unstructured":"Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virol Sep. 2001;1(2):359\u201370.","journal-title":"Virol Sep"},{"issue":"18","key":"536_CR24","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1128\/JVI.00377-08","volume":"82","author":"JL DeHart","year":"2008","unstructured":"DeHart JL, Bosque A, Harris RS, Planelles V. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. J Virol Sep. 2008;82(18):9265\u201372.","journal-title":"J Virol Sep"},{"issue":"4","key":"536_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1128\/CMR.14.4.753-777.2001","volume":"14","author":"SD Lawn","year":"2001","unstructured":"Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol reviews Oct. 2001;14(4):753\u201377. table of contents.","journal-title":"Clin Microbiol reviews Oct"},{"issue":"8","key":"536_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm2450","volume":"9","author":"KA Cimprich","year":"2008","unstructured":"Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat reviews Mol cell biology Aug. 2008;9(8):616\u201327.","journal-title":"Nat reviews Mol cell biology Aug"},{"issue":"4","key":"536_CR27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1128\/MCB.22.4.1049-1059.2002","volume":"22","author":"B Xu","year":"2002","unstructured":"Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)\/M checkpoints are induced by ionizing irradiation. Mol Cell biology Feb. 2002;22(4):1049\u201359.","journal-title":"Mol Cell biology Feb"},{"issue":"1","key":"536_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dnarep.2010.08.005","volume":"2","author":"M Zhang","year":"2011","unstructured":"Zhang M, Qureshi AA, Guo Q, Han J. Genetic variation in DNA repair pathway genes and melanoma risk. DNA repair Jan. 2011;2(1):111\u20136.","journal-title":"DNA repair Jan"},{"issue":"1","key":"536_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cancergencyto.2010.03.006","volume":"1","author":"K Wang","year":"2010","unstructured":"Wang K, Ye Y, Xu Z, et al. Interaction between BRCA1\/BRCA2 and ATM\/ATR associate with breast cancer susceptibility in a chinese Han population. Cancer Genet Cytogenet Jul. 2010;1(1):40\u20136.","journal-title":"Cancer Genet Cytogenet Jul"},{"key":"536_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2407-6-230","volume":"29","author":"F Durocher","year":"2006","unstructured":"Durocher F, Labrie Y, Soucy P, et al. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk french canadian breast\/ovarian cancer families. BMC cancer Sep. 2006;29:6:230.","journal-title":"BMC cancer Sep"},{"issue":"1","key":"536_CR31","first-page":"112","volume":"19","author":"F Tort","year":"2005","unstructured":"Tort F, Hernandez S, Bea S, et al. Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leuk Jan. 2005;19(1):112\u20137.","journal-title":"Leuk Jan"},{"issue":"2","key":"536_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1098-2264(199910)26:2<176::AID-GCC11>3.0.CO;2-3","volume":"26","author":"F Bertoni","year":"1999","unstructured":"Bertoni F, Codegoni AM, Furlan D, Tibiletti MG, Capella C, Broggini M. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes chromosomes & cancer Oct. 1999;26(2):176\u201380.","journal-title":"Genes chromosomes & cancer Oct"},{"issue":"4","key":"536_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10689-010-9360-7","volume":"9","author":"S Solyom","year":"2010","unstructured":"Solyom S, Pylkas K, Winqvist R. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in finnish breast cancer families. Familial cancer Dec. 2010;9(4):537\u201340.","journal-title":"Familial cancer Dec"},{"issue":"7","key":"536_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/j.1460-2075.1994.tb06417.x","volume":"1","author":"S Jinno","year":"1994","unstructured":"Jinno S, Suto K, Nagata A, et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J Apr. 1994;1(7):1549\u201356.","journal-title":"EMBO J Apr"},{"issue":"6811","key":"536_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/35044005","volume":"23","author":"BB Zhou","year":"2000","unstructured":"Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nat Nov. 2000;23(6811):433\u20139.","journal-title":"Nat Nov"},{"issue":"8","key":"536_CR36","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.chembiol.2004.07.007","volume":"11","author":"K Kristjansdottir","year":"2004","unstructured":"Kristjansdottir K, Rudolph J. Cdc25 phosphatases and cancer. Chem biology Aug. 2004;11(8):1043\u201351.","journal-title":"Chem biology Aug"},{"issue":"14","key":"536_CR37","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1096\/fasebj.8.14.7958616","volume":"8","author":"M Doree","year":"1994","unstructured":"Doree M, Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB journal: official publication of the Federation of American Societies for Experimental Biology Nov. 1994;8(14):1114\u201321.","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology Nov"},{"issue":"10\u201311","key":"536_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1139\/o92-138","volume":"70","author":"Y Masui","year":"1992","unstructured":"Masui Y. Towards understanding the control of the division cycle in animal cells. Biochem cell biology = Biochimie et Biol cellulaire Oct-Nov. 1992;70(10\u201311):920\u201345.","journal-title":"Biochem cell biology = Biochimie et Biol cellulaire Oct-Nov"},{"issue":"1","key":"536_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0092-8674(91)90582-J","volume":"4","author":"WG Dunphy","year":"1991","unstructured":"Dunphy WG, Kumagai A. The cdc25 protein contains an intrinsic phosphatase activity. Cell Oct. 1991;4(1):189\u201396.","journal-title":"Cell Oct"},{"issue":"1","key":"536_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol Jan. 1990;1(1):43\u20136.","journal-title":"Epidemiol Jan"},{"issue":"7139","key":"536_CR41","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/bmj.316.7139.1230","volume":"18","author":"J Green","year":"1998","unstructured":"Green J, Britten N. Qualitative research and evidence based medicine. Bmj Apr. 1998;18(7139):1230\u20132.","journal-title":"Bmj Apr"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00536-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00536-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00536-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T15:04:12Z","timestamp":1689779052000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00536-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00536-w","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Harbin Medical University (No.: HMUIRB20180019)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"51"}}